The FDA has kicked off its pilot program for the Drug Supply Chain Security Act by issuing submission requests. TraceLink, the world’s largest integrated digital supply network, submitted its new blockchain solution for the pilot.
The FDA is exploring methods to bolster the safety and security of pharmaceutical distribution. Through the pilot program, the FDA aims to integrate new supply policies.
Blockchain is a software being considered to improve security. The decentralized ledger provides a digital system for records and log transactions, grouping items in chronological order. The software is ideal for tracking supplies.
Trace Histories is TraceLink’s interoperable blockchain network solution. The solution integrates into an organization’s existing infrastructure. Trace Histories was designed by combining 20 years of data on tracking and tracing pharmaceuticals. Trace Histories is designed to help companies meet the 2023 DSCSA requirement for full unit level traceability across the supply chain.
Trace Histories integrates directly into companies’ existing global compliance and serialization infrastructures and leverages the 275,000+ pre-validated trade partners and customers on the TraceLink network.
By 2023, members in the U.S. supply chain must implement a system that meets the new requirements for an interoperable, electronic tracing of pharmaceutical products at the packaging level.